Oscar Health, Inc. (NYSE:OSCR) Stock Position Cut by GSA Capital Partners LLP

GSA Capital Partners LLP cut its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 67.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 37,508 shares of the company's stock after selling 78,923 shares during the quarter. GSA Capital Partners LLP's holdings in Oscar Health were worth $796,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC boosted its position in Oscar Health by 7.5% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company's stock valued at $255,000 after buying an additional 844 shares during the last quarter. American International Group Inc. lifted its stake in shares of Oscar Health by 1.3% in the first quarter. American International Group Inc. now owns 79,411 shares of the company's stock worth $1,181,000 after acquiring an additional 1,009 shares in the last quarter. Summit Trail Advisors LLC boosted its holdings in Oscar Health by 5.4% in the second quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company's stock valued at $329,000 after purchasing an additional 1,065 shares during the last quarter. Arizona State Retirement System grew its stake in Oscar Health by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company's stock valued at $602,000 after purchasing an additional 1,351 shares in the last quarter. Finally, Amalgamated Bank increased its holdings in Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company's stock worth $106,000 after purchasing an additional 1,458 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Price Performance

NYSE OSCR opened at $14.87 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a one year low of $6.93 and a one year high of $23.79. The company has a 50-day simple moving average of $18.20 and a 200-day simple moving average of $18.27.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business's revenue was up 68.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.29) earnings per share. Equities analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on OSCR shares. Piper Sandler reissued an "overweight" rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. UBS Group assumed coverage on shares of Oscar Health in a research note on Monday, October 7th. They set a "neutral" rating and a $23.00 price objective on the stock. Finally, Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and dropped their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $22.93.

Insider Activity at Oscar Health

In other news, Vice Chairman Joshua Kushner bought 276,040 shares of Oscar Health stock in a transaction on Monday, November 11th. The stock was purchased at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the purchase, the insider now directly owns 5,031,262 shares of the company's stock, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of the company's stock in a transaction on Tuesday, November 12th. The stock was purchased at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the purchase, the director now directly owns 5,452,081 shares of the company's stock, valued at $74,584,468.08. This trade represents a 8.36 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 169,569 shares worth $3,007,069. Insiders own 25.11% of the company's stock.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.